Gavin Barlow
Gavin Barlow
Senior Clinical Lecturer in Infection, Hull York Medical School, University of York. Hon. Consultant
Verified email at - Homepage
Cited by
Cited by
Diagnostic and prognostic biomarkers of sepsis in critical care
S Kibe, K Adams, G Barlow
Journal of antimicrobial chemotherapy 66 (suppl_2), ii33-ii40, 2011
Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British …
JAT Sandoe, G Barlow, JB Chambers, M Gammage, A Guleri, P Howard, ...
Journal of Antimicrobial Chemotherapy 70 (2), 325-359, 2015
Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies
AJ Kaasch, G Barlow, JD Edgeworth, VG Fowler Jr, M Hellmich, ...
Journal of Infection 68 (3), 242-251, 2014
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia
G Barlow, D Nathwani, P Davey
Thorax 62 (3), 253-259, 2007
Oral versus intravenous antibiotics for bone and joint infection
HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ...
New England Journal of Medicine 380 (5), 425-436, 2019
Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
D Nathwani, E Rubinstein, G Barlow, P Davey
Clinical infectious diseases 32 (5), 728-741, 2001
Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians, and policy-makers
GD Barlow, DL Lamping, PG Davey, D Nathwani
The Lancet infectious diseases 3 (8), 476-488, 2003
Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis
G Barlow, D Nathwani, F Williams, S Ogston, J Winter, M Jones, P Slane, ...
Thorax 62 (1), 67-74, 2007
Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia
G Barlow, D Nathwani, E Myers, F Sullivan, N Stevens, R Duffy, P Davey
Journal of antimicrobial chemotherapy 61 (2), 442-451, 2008
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
GE Thwaites, M Scarborough, A Szubert, E Nsutebu, R Tilley, J Greig, ...
The Lancet 391 (10121), 668-678, 2018
Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy
D Nathwani, GD Barlow, K Ajdukiewicz, K Gray, J Morrison, B Clift, ...
Journal of Antimicrobial Chemotherapy 51 (2), 391-396, 2003
Community-associated MRSA in the United Kingdom
JWT Elston, GD Barlow
Journal of Infection 59 (3), 149-155, 2009
Sequential antibiotic therapy
GD Barlow, D Nathwani
Current opinion in infectious diseases 13 (6), 599-607, 2000
Is antibiotic resistance a problem? A practical guide for hospital clinicians
G Barlow, D Nathwani
Postgraduate medical journal 81 (961), 680-692, 2005
Procalcitonin: potential role in diagnosis and management of sepsis
T Rowland, H Hilliard, G Barlow
Advances in clinical chemistry 68, 71-86, 2015
Investigation of suspected urinary tract infection in older people
S Ninan, C Walton, G Barlow
Bmj 349, g4070, 2014
Parvovirus B19 causing leucopenia and neutropenia in a healthy adult
GD Barlow, MW McKendrick
Journal of Infection 40 (2), 192-195, 2000
Swine flu and antibiotics
GD Barlow
Journal of antimicrobial chemotherapy 64 (5), 889-894, 2009
Evaluation of the performance of CURB-65 with increasing age
M Parsonage, D Nathwani, P Davey, G Barlow
Clinical microbiology and infection 15 (9), 858-864, 2009
Long-term mortality following bloodstream infection
PJ Lillie, J Allen, C Hall, C Walsh, K Adams, H Thaker, P Moss, GD Barlow
Clinical Microbiology and Infection 19 (10), 955-960, 2013
The system can't perform the operation now. Try again later.
Articles 1–20